A cannabis-derived pharmaceutical drug called Epidiolex has officially been banished from the U.S. Drug Enforcement Administration's (DEA) list of controlled substances.
The medicine, which is FDA-approved,...
Following the EU approval of a cannabis-derived epilepsy treatment called Epidiolex, British drugs company GW Pharmaceuticals is experiencing a major surge in sales.
Headquartered in London, GW Pharma...
A pharmaceutical regulator based in Brazil has given the go-ahead for medical cannabis products to be distributed across the South American country. Anvisa – which is essentially Brazil's version of...
Older patients are steering Germany’s medical cannabis market, with the biggest patient group comprising residents aged between 50 and 59 years of age.
This is according to the latest data published...
People who suffer from dementia could soon be treated with a natural remedy, known as medical cannabis.
Well, that's if the results of a forthcoming trial conducted by Alzheimer’s Research UK come...
Major pharmaceutical drug companies are getting involved in legal cannabis, albeit a bit discreetly.
According to recent reports, patents are being snapped up left, right and center, while some pharmaceutical...
The United Nations has recently reported on Great Britain’s involvement in the cannabis industry, exposing the country for producing more legal cannabis than anywhere else in the world.
Based on...
